BeyondSpring Inc.
For the period ended Dec 31, 2025. Filed Mar 25, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 25, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
PART I
Except as the context otherwise may require, all references to“us,”* “our,” “BeyondSpring,” “we,” the*“Company”* and similar designations refer to Dalian Wanchun Biotechnology Co., Ltd., or Wanchun Biotech, the former holding company of our U.S. subsidiary, and its consolidated subsidiaries, as a whole, prior to the completion of our internal corporate reorganization, and BeyondSpring Inc. and its consolidated subsidiaries, after the completion of our internal corporate reorganization on July 20, 2015. All references in this Annual Report on Form 10-K to*“$,”* “U.S. dollars” and*“dollars”* mean U.S. dollars, all references to*“RMB”* mean Renminbi, the legal currency of China, unless otherwise noted. All references to*“PRC”* or*“China”* in this Annual Report on Form 10-K refer to the People*’s Republic of China.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.